Inventor · disambiguated record
Angelo Guainazzi
Also filed as: GUAINAZZI ANGELO
7 granted patents·2 pending applications·10 citations·filing 2015–2025
79Inventor score
Technology areasA61P
Files withHELSINN HEALTHCARE SA9
Top patents by PatentIndex Score
9 records- 0183US9546157B2Asymmetric piperidinyl-substituted ureas as medicinesHELSINN HEALTHCARE SA·Filed 2015·Granted Jan 17, 2017·4 cites·38 claims
- 0281US12440485B2Centrally-active ghrelin agonist and medical uses thereofHELSINN HEALTHCARE SA·Filed 2024·Granted Oct 14, 2025·0 cites·28 claims
- 0379US10577384B2Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2018·Granted Mar 3, 2020·2 cites·15 claims
- 0478US12005056B2Centrally-active ghrelin agonist and medical uses thereofHELSINN HEALTHCARE SA·Filed 2019·Granted Jun 11, 2024·2 cites·22 claims
- 0578US9926337B2Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 27, 2018·2 cites·19 claims
- 0677US2025367181A1Centrally-Active Ghrelin Agonist and Medical Uses ThereofHELSINN HEALTHCARE SA·Filed 2025·Application pending·0 cites
- 0770US11884646B2Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, methods of preparation, and uses thereofHELSINN HEALTHCARE SA·Filed 2022·Granted Jan 30, 2024·0 cites·27 claims
- 0863US2020262850A1Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2020·Application pending·0 cites
- 0956US11299472B2Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereofHELSINN HEALTHCARE SA·Filed 2018·Granted Apr 12, 2022·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Angelo Guainazzi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →